SHSE:688580 (China)
Â
Class A
Â¥
50.02
+0.92 (+1.87%)
Aug 7
Business Description
Nanjing Vishee Medical Technology Co Ltd
ISIN : CNE1000041Q0
Share Class Description:
SHSE:688580: Class ATotal Employee Number:
635Compare
Compare
Traded in other countries / regions
688580.China Index Membership
SSE Composite Index IPO Date
2020-07-21Description
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2345.81 | |||||
Equity-to-Asset | 0.94 | |||||
Interest Coverage | 140.17 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 28.33 | |||||
Beneish M-Score | -2.19 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.8 | |||||
3-Year EBITDA Growth Rate | 14.1 | |||||
3-Year EPS without NRI Growth Rate | 16.6 | |||||
3-Year Book Growth Rate | 3.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 17.73 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 16.16 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.56 | |||||
9-Day RSI | 48.02 | |||||
14-Day RSI | 45.6 | |||||
3-1 Month Momentum % | -3.36 | |||||
6-1 Month Momentum % | 8.23 | |||||
12-1 Month Momentum % | 18.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 9.65 | |||||
Quick Ratio | 9.31 | |||||
Cash Ratio | 8.71 | |||||
Days Inventory | 92.23 | |||||
Days Sales Outstanding | 16.58 | |||||
Days Payable | 42.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.2 | |||||
Dividend Payout Ratio | 0.57 | |||||
3-Year Dividend Growth Rate | -4.9 | |||||
Forward Dividend Yield % | 2.2 | |||||
5-Year Yield-on-Cost % | 2.17 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 2.16 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 66.09 | |||||
Operating Margin % | 28.55 | |||||
Net Margin % | 35.2 | |||||
EBITDA Margin % | 39.91 | |||||
FCF Margin % | 1.32 | |||||
OCF Margin % | 36 | |||||
ROE % | 9.92 | |||||
ROA % | 9.05 | |||||
ROIC % | 15.88 | |||||
3-Year ROIIC % | 13.61 | |||||
ROC (Joel Greenblatt) % | 42 | |||||
ROCE % | 11.24 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 28.91 | |||||
Forward PE Ratio | 29.04 | |||||
PE Ratio without NRI | 35.6 | |||||
Shiller PE Ratio | 42.35 | |||||
Price-to-Owner-Earnings | 71.66 | |||||
PS Ratio | 10.18 | |||||
PB Ratio | 2.73 | |||||
Price-to-Tangible-Book | 3.06 | |||||
Price-to-Free-Cash-Flow | 847.8 | |||||
Price-to-Operating-Cash-Flow | 28.32 | |||||
EV-to-EBIT | 19.99 | |||||
EV-to-EBITDA | 19.99 | |||||
EV-to-Revenue | 7.98 | |||||
EV-to-FCF | 602.67 | |||||
Price-to-GF-Value | 0.91 | |||||
Price-to-Projected-FCF | 2.89 | |||||
Price-to-Graham-Number | 2.2 | |||||
| Price-to-Net-Current-Asset-Value | 5.18 | |||||
| Price-to-Net-Cash | 5.82 | |||||
Earnings Yield (Greenblatt) % | 5 | |||||
FCF Yield % | 0.13 | |||||
Forward Rate of Return (Yacktman) % | -5.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanjing Vishee Medical Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 472.853 | ||
| EPS (TTM) (Â¥) | 1.73 | ||
| Beta | 1.8407 | ||
| 3-Year Sharpe Ratio | 0.18 | ||
| 3-Year Sortino Ratio | 0.31 | ||
| Volatility % | 49.8 | ||
| 14-Day RSI | 45.6 | ||
| 14-Day ATR (Â¥) | 2.905499 | ||
| 20-Day SMA (Â¥) | 50.544 | ||
| 12-1 Month Momentum % | 18.15 | ||
| 52-Week Range (Â¥) | 43.2 - 72.27 | ||
| Shares Outstanding (Mil) | 95.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanjing Vishee Medical Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanjing Vishee Medical Technology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 1.082000 Cash Dividend | 2026-06-18 | 53.56 (+0.87%) | ||
| CNY 0.800000 Cash Dividend | 2025-06-17 | 46.20 (+1.45%) | ||
| 1.4:1 Stock Split | 2024-06-05 | 31.42 (+0.25%) |
Show
Entries
Nanjing Vishee Medical Technology Co Ltd Frequently Asked Questions
What is Nanjing Vishee Medical Technology Co Ltd(SHSE:688580)'s stock price today?
The current price of SHSE:688580 is ¥50.02. The 52 week high of SHSE:688580 is ¥72.27 and 52 week low is ¥43.20.
When is next earnings date of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580)?
The next earnings date of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) is .
Does Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) pay dividends? If so, how much?
The Dividend Yield %  of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) is 2.2% (As of Today), Highest Dividend Payout Ratio of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) was 1.24. The lowest was 0.39. And the median was 0.63. The  Forward Dividend Yield % of Nanjing Vishee Medical Technology Co Ltd(SHSE:688580) is 2.2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nanjing Vishee Medical Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers